PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+14.4%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.62B
AUM Growth
+$77.5M
(+5%)
Cap. Flow
-$75.6M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103
Top Buys
| 1 |
NVIDIA
NVDA
|
+$4.03M |
| 2 |
Broadcom
AVGO
|
+$3.21M |
| 3 |
Tesla
TSLA
|
+$2.65M |
| 4 |
Viking Therapeutics
VKTX
|
+$1.64M |
| 5 |
Texas Instruments
TXN
|
+$1.6M |
Top Sells
| 1 |
AbbVie
ABBV
|
+$27.3M |
| 2 |
Danaher
DHR
|
+$16.8M |
| 3 |
Amgen
AMGN
|
+$12.2M |
| 4 |
Gilead Sciences
GILD
|
+$9.54M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$7.75M |
Sector Composition
| 1 | Technology | 33.28% |
| 2 | Healthcare | 16.86% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Communication Services | 8.63% |
| 5 | Energy | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
iQIYI
IQ
$2.69B
| $896K | 0.06% |
123,111
+4,295
| +4% | +$31.3K |
|
327
Crown Castle
CCI
$41.2B
| $893K | 0.06% |
6,673
-2,052
| -24% | -$275K |
|
328
Agios Pharmaceuticals
AGIO
$2.1B
| $885K | 0.05% |
+38,524
| New | +$885K |
|
329
89bio
ETNB
$1.28B
| $884K | 0.05% |
+58,076
| New | +$884K |
|
330
Avidity Biosciences
RNA
$6B
| $881K | 0.05% |
+57,365
| New | +$881K |
|
331
TotalEnergies
TTE
$134B
| $879K | 0.05% |
14,882
+1,136
| +8% | +$67.1K |
|
|
CTIC
332
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $876K | 0.05% |
+208,517
| New | +$876K |
|
333
AB InBev
BUD
$116B
| $871K | 0.05% |
13,050
+996
| +8% | +$66.5K |
|
334
HSBC
HSBC
$230B
| $867K | 0.05% |
25,414
+1,940
| +8% | +$66.2K |
|
335
Sea Limited
SE
$114B
| $866K | 0.05% |
10,005
-1,285
| -11% | -$111K |
|
336
FibroGen
FGEN
$46.3M
| $865K | 0.05% |
+1,855
| New | +$865K |
|
337
DuPont de Nemours
DD
$32.1B
| $865K | 0.05% |
12,054
-2,405
| -17% | -$173K |
|
|
CHX
338
DELISTED
ChampionX
CHX
| $861K | 0.05% |
31,753
-9,190
| -22% | -$249K |
|
339
General Motors
GM
$55.2B
| $860K | 0.05% |
23,439
+6,600
| +39% | +$242K |
|
340
HCA Healthcare
HCA
$96.8B
| $856K | 0.05% |
3,247
-229
| -7% | -$60.4K |
|
341
SolarEdge
SEDG
$1.78B
| $853K | 0.05% |
2,808
+695
| +33% | +$211K |
|
342
Huazhu Hotels Group
HTHT
$11.4B
| $853K | 0.05% |
17,416
-11,306
| -39% | -$554K |
|
343
United Microelectronic
UMC
$17.3B
| $851K | 0.05% |
97,158
-25,862
| -21% | -$227K |
|
344
Myriad Genetics
MYGN
$649M
| $846K | 0.05% |
+36,397
| New | +$846K |
|
345
CenterPoint Energy
CNP
$24.5B
| $842K | 0.05% |
28,592
-1,609
| -5% | -$47.4K |
|
346
BridgeBio Pharma
BBIO
$10.2B
| $842K | 0.05% |
+50,773
| New | +$842K |
|
347
Petrobras
PBR
$79.4B
| $839K | 0.05% |
80,465
-2,941
| -4% | -$30.7K |
|
348
Viridian Therapeutics
VRDN
$1.65B
| $837K | 0.05% |
+32,900
| New | +$837K |
|
349
Teradyne
TER
$18.3B
| $837K | 0.05% |
7,783
+1,772
| +29% | +$191K |
|
350
Colgate-Palmolive
CL
$68.1B
| $834K | 0.05% |
11,093
+1,897
| +21% | +$143K |
|